List of Excipients in API sodium phenylbutyrate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sodium phenylbutyrate
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Medunik USA | PHEBURANE | sodium phenylbutyrate | 71770-100 | ETHYLCELLULOSES | |
Medunik USA | PHEBURANE | sodium phenylbutyrate | 71770-100 | HYPROMELLOSE 2910 | |
Medunik USA | PHEBURANE | sodium phenylbutyrate | 71770-100 | POLYETHYLENE GLYCOL 1500 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing sodium phenylbutyrate
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 | CALCIUM STEARATE |
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 | SILICON DIOXIDE |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 | CALCIUM STEARATE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for sodium phenylbutyrate
Excipient focus: ACACIA
sodium phenylbutyrate drug variants containing ACACIA
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing ACACIA
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: CALCIUM STEARATE
sodium phenylbutyrate drug variants containing CALCIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing CALCIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Medunik USA | sodium phenylbutyrate | 71770-100 |
Medunik USA | sodium phenylbutyrate | 71770-210 |
Horizon Therapeutics USA Inc | sodium phenylbutyrate | 75987-060 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sodium phenylbutyrate drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
Horizon Therapeutics USA Inc | sodium phenylbutyrate | 75987-060 |
Par Pharmaceutical Inc | sodium phenylbutyrate tablets, 500 mg | 49884-170 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
Medunik USA | sodium phenylbutyrate | 71770-100 |
>Company | >Ingredient | >NDC |
Excipient focus: DEXTRATES
sodium phenylbutyrate drug variants containing DEXTRATES
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing DEXTRATES
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSES
sodium phenylbutyrate drug variants containing ETHYLCELLULOSES
Company | Ingredient | NDC |
---|---|---|
Medunik USA | sodium phenylbutyrate | 71770-100 |
Medunik USA | sodium phenylbutyrate | 71770-210 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing ETHYLCELLULOSES
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
sodium phenylbutyrate drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Medunik USA | sodium phenylbutyrate | 71770-100 |
Medunik USA | sodium phenylbutyrate | 71770-210 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
sodium phenylbutyrate drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
Horizon Therapeutics USA Inc | sodium phenylbutyrate | 75987-060 |
Par Pharmaceutical Inc | sodium phenylbutyrate tablets, 500 mg | 49884-170 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
Medunik USA | sodium phenylbutyrate | 71770-100 |
>Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
sodium phenylbutyrate drug variants containing MALTODEXTRIN
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing MALTODEXTRIN
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
sodium phenylbutyrate drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 1500
sodium phenylbutyrate drug variants containing POLYETHYLENE GLYCOL 1500
Company | Ingredient | NDC |
---|---|---|
Medunik USA | sodium phenylbutyrate | 71770-100 |
Medunik USA | sodium phenylbutyrate | 71770-210 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing POLYETHYLENE GLYCOL 1500
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K25
sodium phenylbutyrate drug variants containing POVIDONE K25
Company | Ingredient | NDC |
---|---|---|
Medunik USA | sodium phenylbutyrate | 71770-100 |
Medunik USA | sodium phenylbutyrate | 71770-210 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing POVIDONE K25
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
sodium phenylbutyrate drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Medunik USA | sodium phenylbutyrate | 71770-100 |
Medunik USA | sodium phenylbutyrate | 71770-210 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
sodium phenylbutyrate drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
sodium phenylbutyrate drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
sodium phenylbutyrate drug variants containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
sodium phenylbutyrate drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Medunik USA | sodium phenylbutyrate | 71770-100 |
Medunik USA | sodium phenylbutyrate | 71770-210 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
sodium phenylbutyrate drug variants containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
sodium phenylbutyrate drug variants containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
Medunik USA | sodium phenylbutyrate | 71770-100 |
Medunik USA | sodium phenylbutyrate | 71770-210 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate drug variants not containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
Sigmapharm Laboratories LLC | sodium phenylbutyrate | 42794-086 |
Par Pharmaceutical Inc | sodium phenylbutyrate | 49884-006 |
GLENMARK PHARMACEUTICALS INC USA | sodium phenylbutyrate | 68462-853 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.